ArticleNeuroepidemiology2014
Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets.
Article in Neuroepidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
43 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016Pooled it
- Differences in Cognitive Aging Assessments Associated With Retest Effects.JAMA network open · 2026Trial
- Cognitive benefits of hearing intervention vary by risk of cognitive decline: A secondary analysis of the ACHIEVE trial.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Trial
- Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial.Lancet (London, England) · 2023Trial
- How to distinguish promotion, prevention, and treatment trials in public mental health: development and validation of the VErona-LUgano Tool (VELUT).Epidemiology and psychiatric sciences · 2025Article
- Diabetes and cognitive health in India: a nationally representative survey of adults aged 45 years and older.BMJ open · 2025Article
- Rethinking neuropsychological test validity in dementia assessment: a critical review in the age of neuroimaging and digital markers.Frontiers in human neuroscience · 2025Review
- The Relationship Between 10-year Changes in Cognitive Ability and Subsequent Mortality: Findings from the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) Trial.American journal of epidemiology · 2024Article
- Traumatic brain injury and cognitive change over 30 years among community-dwelling older adults.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Article
- Article
- The Early-Onset Alzheimer's Disease Whole-Genome Sequencing Project: Study design and methodology.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023Article
- Harmonizing Ethno-Regionally Diverse Datasets to Advance the Global Epidemiology of Dementia.Clinics in geriatric medicine · 2023Review
- The NEI VFQ-25C: Calibrating Items in the National Eye Institute Visual Function Questionnaire-25 to Enable Comparison of Outcome Measures.Translational vision science & technology · 2022Article
- The effect of missing data and imputation on the detection of bias in cognitive testing using differential item functioning methods.BMC medical research methodology · 2022Article
- Is there a common latent cognitive construct for dementia estimation across two Chinese cohorts?Alzheimer's & dementia (Amsterdam, Netherlands) · 2022Article
- Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease.Journal of Alzheimer's disease : JAD · 2022Article
- Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis.Breast cancer research and treatment · 2022Article
- Pre-statistical harmonization of behavrioal instruments across eight surveys and trials.BMC medical research methodology · 2021Article
- Pre-Statistical Considerations for Harmonization of Cognitive Instruments: Harmonization of ARIC, CARDIA, CHS, FHS, MESA, and NOMAS.Journal of Alzheimer's disease : JAD · 2021Article
- Genome-wide association study of rate of cognitive decline in Alzheimer's disease patients identifies novel genes and pathways.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundWe sought to identify optimal approaches by calibrating longitudinal cognitive performance across studies with different neuropsychological batteries.
methodsWe examined four approaches to calibrate cognitive performance in nine longitudinal studies of Alzheimer's disease (AD) (n = 10,875): (1) common test, (2) standardize and average available tests, (3) confirmatory factor analysis (CFA) with continuous indicators, and (4) CFA with categorical indicators. To compare precision, we determined the minimum sample sizes needed to detect 25% cognitive decline with 80% power. To compare criterion validity, we correlated cognitive change from each approach with 6-year changes in average cortical thickness and hippocampal volume using available MRI data from the AD Neuroimaging Initiative.
resultsCFA with categorical indicators required the smallest sample size to detect 25% cognitive decline with 80% power (n = 232) compared to common test (n = 277), standardize-and-average (n = 291), and CFA with continuous indicators (n = 315) approaches. Associations with changes in biomarkers changes were the strongest for CFA with categorical indicators.
conclusionsCFA with categorical indicators demonstrated greater power to detect change and superior criterion validity compared to other approaches. It has wide applicability to directly compare cognitive performance across studies, making it a good way to obtain operational phenotypes for genetic analyses of cognitive decline among people with AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.